Cary O. Harding

Phenylketonuria Scientific Review Conference: State of the science and future research needs

Kathryn Camp, Melissa A. Parisi, Phyllis B. Acosta et al. · Molecular Genetics and Metabolism · 2014 · 269 citations

Medicine, Biochemistry, Molecular Medicine +8

Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs

Eunju Kang, Xinjian Wang, Rebecca Tippner-Hedges et al. · Cell stem cell · 2016 · 218 citations · Full text

Life Sciences, Cell Biology, Genetics +14

Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)

Janet A. Thomas, Harvey L. Levy, Stephen Amato et al. · Molecular Genetics and Metabolism · 2018 · 183 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6<i>R</i>‐tetrahydrobiopterin): a phase II, multicentre, open‐label, screening study

Barbara K. Burton, Dorothy K. Grange, Andrzej Milanowski et al. · Journal of Inherited Metabolic Disease · 2007 · 171 citations

Pharmacy, Pharmacology, Pharmacotherapy +7

Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial

Nicola Longo, Cary O. Harding, Barbara K. Burton et al. · The Lancet · 2014 · 167 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +6